Xstrahl in Action: SARRP Assists in EPR-Mediated Tumor Targeting

May 20, 2020

[:us]In the study, EPR-Mediated Tumor Targeting using Ultrasmall-hybrid Nanoparticles: From Animal to Human with Theranostic AGuIX Nanoparticles, SARRP was used to experience the therapeutic action of enhanced permeability and retention (EPR)-mediated tumor targeting using AGuIX® NPs at low dose specifically when accumulated and activated at the tumor site.

See more below, or the full study here.


Contact Us

Find out more about how Xstrahl will work tirelessly for you

Explore Related Posts